麻豆传媒

Dr. Christopher Ohl is an infectious disease specialist in Winston Salem, North Carolina and is affiliated with multiple hospitals in the area, including Wake Forest Baptist Health-Lexington Medical Center and Wake Forest Baptist Medical Center. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice for more than 20 years. 

Dr. S. Wesley Long received his MD degree in 2007 from The University of Texas Medical Branch (UTMB) in Galveston TX, where he also earned a PhD in Experimental Pathology. After finishing his doctoral studies, Dr. Long completed a clinical pathology residency at Houston Methodist. He currently serves as a member of the Editorial Board for Archives of Pathology and Laboratory Medicine. Dr. Long’s research centers on functional genomics of multidrug-resistant bacterial strains to identify novel drug targets. He is currently focusing his work on MRSA (methicillin-resistant Staphylococcus aureus) and Klebsiella pneumoniae, both of which readily acquire resistance to several different types of antibiotics and are prevalent in the hospital setting.

Dr Kristen Reyher is based in the Bristol Veterinary School. Her main areas of research are cattle disease (especially mastitis), veterinary-farmer communication and antimicrobial resistance, use and stewardship in farmed animals and across the One Health sphere. She combines her clinical expertise with the best in veterinary evidence using quantitative and qualitative research across the basic sciences, epidemiology and applied clinical practice. She leads the AMR Force, a 拢10-million funded interdisciplinary research group focussed on antimicrobial resistance, use and stewardship. One of her current research thrusts is an ambitious project designing a One Health data platform for antimicrobial resistance research. Dr Reyher helps to share best practice between farmers and directed the first studies applying a counselling style called Motivational Interviewing to veterinarian-client communication. She has worked in livestock veterinary practice in three countries and has worked with farmers in various others including Argentina and Thailand. Her accomplishments include successfully organising the data collection platform for Canada鈥檚 largest livestock research effort through the Canadian Bovine Mastitis Research Network.

Education
1998 - BSc Zoology, University of Florida
2002 - D.V.M Veterinary Medicine, College of Veterinary Medicine, Cornell University
2012 - PhD Epidemiology, University of Prince Edward Island

Accomplishments
2018 - Public Health England Antibiotic Guardian Awards 鈥� Winner, 2019 - Public Health England Antibiotic Guardian Awards 鈥� Winner, Veterinary Record Impact Award for publication, UK Diagnostic Summit 鈥� Highly Commended Award for Research

Dr. Huang鈥檚 research focuses on the clinical epidemiology of highly antibiotic-resistant organisms including estimating the risk for infection and assessing practical means for prevention. Dr. Huang鈥檚 work involves studying the risks of healthcare-associated transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE), including both short and long-term sequelae due to these pathogens within and beyond the hospital stay. Her scope of research also includes an evaluation of inter-facility spread and containment of these pathogens, including the intersection of preventative measures on hospital networks, affiliated nursing homes, and surrounding communities. She has evaluated several strategies to mitigate transmission and disease, including active surveillance and institution of contact precautions, enhanced environmental cleaning, and, most recently, leading several large individual and cluster randomized trials of decolonization to reduce multidrug-resistant organisms and healthcare-associated infections.

Dr. Huang has also built a population laboratory in a large metropolitan county in Southern California (Orange County, CA). She has performed detailed data collection across all hospitals and nursing homes in this county, including extensive details on inter-facility patient sharing, infection control practices, and ICUs, non-ICUs, and nursing homes estimates of pathogen burden in this county. These detailed population data are the foundation for a dynamic transmission model of Orange County facilities and communities built through the NIH Models of Infectious Disease Agent Study (MIDAS) collaborative. This model will allow simulation of intervention strategies as well as prediction of future trends in transmission and disease burden for MRSA and other pathogens.
Beyond MRSA, Dr. Huang is broadly interested in the measurement and prevention of healthcare associated infections. She has evaluated more efficient ways to look at relative hospital rankings using administrative data, and has balanced this with rigorous in depth assessments related to accuracy and completeness of reporting. She has specific interests in the use of automated hospital and claims data to assess pathogen clusters and surgical site infections.

Cari Vanderpool is a professor of microbiology and the associate dean for research in the College of Liberal Arts & Sciences at the University of Illinois.
She joined the University of Illinois faculty in 2006 after completing her PhD at the University of Minnesota and postdoctoral training at the National Institutes of Health. Her research focuses on the fundamental biology of bacteria and the viruses that infect them (bacteriophages or phages). Her research group uses tools of biochemistry, genetics, molecular biology, and genomics to investigate bacterial interactions with each other and with their plant and animal hosts. One of the overall goals of her research is to understand how bacteria sense different environmental conditions and respond by changing their gene expression, cellular structure, and behaviors in ways that allow them to succeed in very diverse and sometimes harsh environments. This work is necessary to reveal how bacteria in the complex communities known as microbiomes contribute to human and animal and plant health.  
Phages are the most abundant biological entity on the planet and bacteria must constantly defend themselves against this natural predator. Dr. Vanderpool’s group is studying how phages interact with an array of bacterial species and how these interactions shape bacterial populations in a variety of natural environments, from the human gut to the soil. Bacteria are engaged in an “arms race” with the phages that target them, characterized by bacterial defense and phage counter-defense mechanisms and Dr. Vanderpool’s group is also studying these processes. There is a great deal of interest in harnessing the natural bacterial killing properties of phages for a range of biotechnology applications. Phages show special promise as an alternative to antibiotic therapies, and thus may help solve the looming antibiotic resistance crisis. Dr. Vanderpool’s group is embarking on new applied research directions that may lead to breakthroughs in use of phages as therapies for a range of human diseases.
For more about her research, visit . 

Research Topics
Genetics, Genomics, Metabolic Regulation, Microbial Physiology, Regulation of Gene Expression, RNA Biology, Signal Transduction

Education

BS Microbiology, Purdue University, 1998
PhD Microbiology, Immunology and Cancer Biology, University of Minnesota, 1998-2003
Postdoctoral Fellow, National Cancer Institute, 2003-2006